Company & Sponsor Intelligence

Janssen Research & Development, LLC

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials11

Recruiting0

Completed8

Countries3

Therapeutic footprint

alzheimersautismdepressionschizophrenia

Indexed studies

NCT02462473A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
schizophrenia · United StatesPHASE2

NCT04619420A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease
alzheimers · United StatesPHASE2

NCT04533529A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant
depression · United StatesPHASE3

NCT04532749A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
depression · United StatesPHASE3

NCT04571697A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
alzheimers · United StatesCOMPLETED

NCT01978548A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease
alzheimers · BelgiumPHASE1

NCT01887535A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Participants
alzheimers · BelgiumPHASE1

NCT02114372Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study
alzheimers · United KingdomCOMPLETED

NCT04599855A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
depression · United StatesPHASE4

NCT02668991Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
autism · United StatesCOMPLETED

NCT05307692A Study of Seltorexant in Participants With Probable Alzheimer's Disease
alzheimers · United StatesPHASE2

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →